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Abstract. In this paper, a deep learning-based approach is applied to high 
dimensional, high-volume, and high-sparsity medical data to identify critical 
casual attributions that might affect the survival of a breast cancer patient. The 
Surveillance Epidemiology and End Results (SEER) breast cancer data is 
explored in this study. The SEER data set contains accumulated patient-level 
and treatment-level information, such as cancer site, cancer stage, treatment 
received, and cause of death. Restricted Boltzmann machines (RBMs) are 
proposed for dimensionality reduction in the analysis. RBM is a popular 
paradigm of deep learning networks and can be used to extract features from a 
given data set and transform data in a non-linear manner into a lower 
dimensional space for further modelling. In this study, a group of RBMs has 
been trained to sequentially transform the original data into a very low 
dimensional space, and then the k-means clustering is conducted in this space. 
Furthermore, the results obtained about the cluster membership of the data 
samples are mapped back to the original sample space for interpretation and 
insight creation. The analysis has demonstrated that essential features relating 
to breast cancer survival can be effectively extracted and brought forward into a 
much lower dimensional space formed by RBMs. 
Keywords: Restricted Boltzmann Machines, Deep Learning, Survival Analysis, 
k-means Clustering Analysis, Principal Component Analysis. 
1 Introduction 
Breast cancer is the most diagnosed cancer in women, affecting over 2.1 million 
women each year globally, and it causes the greatest number of cancer-related deaths 
among women. In 2018, it is estimated that 627,000 women died from breast cancer – 
that is approximately 15 of all cancer deaths among women [1].  
In order to improve breast cancer survival and life expectancy, it is crucial to learn 
and understand the factors that might affect breast cancer survival rate and outcomes 
following certain treatments. In the past years, enormous studies have been 
undertaken intensively in this area aiming to identify the causal attributions of breast 
cancer survival from multiple perspectives including biological, diagnostical, and data 
mining techniques.  
From an analytical point of view, analysing breast cancer data has been challenged 
by a) The volume of the data to be explored tends to be quite big since it has been 
accumulated for several decades. For example, the SEER (Surveillance Epidemiology 
and End Results) data set [2] contains some 291,760 breast cancer incidences 
collected from 1974 up to date; and b) The number of variables (features) of the data 
usually is considerably high, e.g., over a thousand or even more. The high 
dimensionality is mainly caused by the categorical variables contained in the data that 
may have many distinct symbolic values, since each of the distinct values of a 
categorical variable needs to be transformed into a unit vector using, for example, the 
one-hot encoding (orthogonal encoding) method to make a categorical variable 
applicable for an algorithm. Due to these factors, some typical data mining 
algorithms, such as the k-means clustering algorithm, may not perform well with high 
dimensionality, high volume, and high sparsity data.  
The k-means clustering algorithm is a widely used unsupervised descriptive 
modelling approach for grouping (segmenting) a given data set based on similarities 
among the data samples with respect to the values taken by certain variables involved. 
The algorithm is simple, effective in general, and can converge within a few 
iterations. However, the algorithm has several problems when applied to a data set 
with high dimensionality and high sparsity: 
1. The typical Euclidean distance for similarity measure is inefficient when the 
number of variables is large, and the number of samples is relevantly small 
[3]; 
2. The computational complexity of the algorithm increases with the number of 
dimensions [4]; and 
3. It is difficult to determine the cluster centroids if the data values are sparse, 
i.e., only a small number of data entries having a non-null value. An example 
of such a data is the resultant data set transformed from a data that contains 
many categorical variables using the one-hot encoding method. This can also 
be viewed as an asymmetry data matrix. In addition, sparsity has made the 
algorithm very sensitive to noise.  
To address the high dimensionality problem involved in the k-means clustering, a 
proper dimensionality reduction approach is usually considered. The principal 
component analysis (PCA) is a popular approach for such a purpose. PCA forms a 
linear transformation to transform the original data into a new space spanned by a set 
of principal components. Depending on the significance of each principal component, 
only a few significant principal components could be selected to form a subspace with 
a low dimensionality, and then the k-means clustering can be performed in the 
subspace. The PCA-based subspace clustering approach has been applied to medical 
image segmentation [5].  
It should be noted that data samples may become insufficient when dealing with 
high dimensional data since it may lead a modelling process that involves too many 
parameters to learn and/or to optimize with relatively a very small number of samples.   
In this paper, a deep learning-based approach is applied to identify critical casual 
attributions that might affect the survival of a breast cancer patient. The SEER breast 
cancer data is explored in this study. The data set contains rich patient-level and 
treatment-level information on breast cancer incidences, such as cancer site, cancer 
stage, treatment received, and cause of death. Restricted Boltzmann machines 
(RBMs) are proposed for dimensionality reduction in the present analysis. RBM is a 
popular paradigm of deep learning networks and can be used to extract features from 
a given data set. RBMs transform data in a non-linear manner into a lower 
dimensional space for further modelling, for instance, clustering analysis and 
classification. In this study, a group of RBMs has been trained to sequentially 
transform the original data into a very low dimensional space, and then the k-means 
clustering is conducted in this space. Furthermore, the results obtained about the 
cluster membership of the data samples are mapped back to the original space for 
interpretation and insight creation. The analysis has demonstrated that essential 
features in the data set can be effectively extracted and brought forward into a much 
lower dimensionality space formed by RBMs. 
The remainder of this paper is organized as follows. Section 2 provides a literature 
review on the relevant works in relation to diagnosis analytics in breast cancer data. 
Section 3 discusses in detail the methodology adopted in this study including the 
entire analytical process and RBMs. The SEER data set is described in Section 4 
along with the essential data pre-processing performed on the data. Section 5 gives a 
detailed account about the analysis experiments, and further in Section 6, the findings 
from the analysis are interpreted and summarized. Finally, in Section 7, concluding 
remarks are discussed and the further research is outlined.  
2 Relevant Works 
Data mining techniques have been widely used in medical research, and especially, in 
medical diagnosis of diverse types of cancer. Various models have been developed for 
this purpose including qualitative models [6][7][8][9], quantitative models [10][11], 
and hybrid models [12]. Very recently, many deep learning-based models have been 
considered in several case studies [13]. 
Segmenting breast cancer patients was studied in [6] and it was found that the 
number and the types of the resultant clusters were similar in terms of symptom 
occurrence rates or symptom severity ratings. Five clusters were identified using 
symptom occurrence rates while six clusters were established using symptom severity 
ratings. The types of clusters were also similar. A bisecting k-means algorithm was 
applied to analyze three diseases: breast cancer, Type 1 diabetes, and fibromyalgia in 
[7]. Their results showed that, although the clusters established were different from 
each other, all the clusters had several common features. In [8] the time effect and 
symptom for patients who received chemotherapy was examined using clustering 
analysis. An ensemble learning-based algorithm for lung cancer diagnosis was 
investigated [14]. The algorithm can achieve a high classification accuracy with a low 
false no-cancer rate (false negative rate). The model contained two levels. The first 
level consisted of a group of individual neural networks which can be used to identify 
if a cell is a cancer cell or not. A cell was considered a cancer cell if any network 
classified it a cancer cell. The second level employed a group of neural networks to 
determine which type of cancer a recognized cancer cell belongs to. This algorithm 
has implemented a certain classification scheme. A Bayesian network structure was 
proposed for canner diagnosis purpose [10]. The network can be trained using a direct 
causal learner algorithm and has been applied to both simulated and real data sets.  
In addition, algorithms for dimensionality reduction and feature extraction have 
also been considered. A two-step algorithm was investigated to address the high 
dimensionality problem in genes analysis [15]. Interestingly in [16] a statistical test 
and genetic algorithm was utilized for feature selection, and further leave-one-out 
cross validation was used along with receiver operating characteristic curve to 
identify which features to be used in order to achieve the best classification 
performance. Several real-life data sets were chosen to testify and evaluate the 
effectiveness of the algorithm.  
Comparing different data mining algorithms for a better cancer risk or survival rate 
prediction and classification has received a great research attention. In [12] various 
Bayesian-based classifiers were explored for the prediction of the survival rate of 6 
months after treatment, including naive Bayesian classifier, selective naive Bayesian 
classifier, semi-naive Bayesian classifier, tree-augmented naive Bayesian classifier, 
and k-dependence Bayesian classifier. The performance of all these classifiers were 
evaluated and compared. Artificial neural networks (ANNs) were employed to 
examine mammograms [11]. The work has demonstrated that ANNs with two hidden 
layers performed better than ANNs with only one hidden layer. In [17] logistic 
regression, ANNs, and Bayesian networks were compared for accuracy. Their results 
showed that the Bayesian model outperformed other methods.  
Sensible new knowledge can be discovered when applying data mining algorithms 
in medicine. Yang [18] proposed a vicinal support vector classifier to handle data 
from different probability distributions. The proposed method had two steps: 
clustering and training. In the first step, a supervised kernel-based deterministic 
annealing clustering algorithm was applied to partition the train data into different soft 
vicinal areas in the feature space. By doing so, they constructed vicinal kernel 
functions. In the training step, the objective function, called vicinal risk function, was 
minimized under the constraints of the vicinal areas defined in the clustering step. 
Kakushadze [19] applied k-means to cluster different types of cancer with genome 
data without using nonnegative matrix factorization. They found that, out of 14 types 
of cancer, three had no cluster-like structures, two had high within-cluster 
correlations, and the others had common structure.  
In conclusion, many data mining technologies such as neural networks and 
Bayesian networks are applied to construct cancer diagnosis models. The constructed 
models can diagnose various cancer and have shown a high accuracy. On the other 
hand, there is still a clear lack of dealing with high-dimensional and high-sparsity 
medical data.  
3 Methodology 
In this paper a deep learning-based approach is proposed for feature extract and 
dimensionality reduction in order to identify crucial casual attributions with high 
dimensional, high-volume, and high-sparsity breast cancer data. The entire analysis 
process is illustrated conceptually in Figure 1 and the key techniques applied are 
discussed below.  
 
Fig. 1. The analysis process with the key steps. 
3.1 Restricted Boltzmann Machines for Dimensionality Reduction and 
Feature Extraction  
RBMs are used in this research for feature extraction and dimensionality reduction. 
Using an RBM, data from an original high-dimensional space can be transformed into 
a feature space with a much smaller number of dimensions for analysis, such as the k-
means clustering. It is our intention in this study to examine if this approach can 
effectively address the issues relating to cluster analysis in a high-dimensional and 
highly-sparse space in order to partition the breast cancer patients into various 
meaningful groups based on their similarities in relation to a set of features and 
measures.  
A typical topology of RBM is shown in Figure 2. An RBM is an energy-based 
generative statistical model with hidden and visible variables [21]. The energy of the 
visible node state and hidden node state is defined as 
 
        𝐸(𝑣, ℎ) = − ∑ 𝑏𝑖𝑣𝑖𝑖∊𝑣𝑖𝑠𝑖𝑏𝑙𝑒 − ∑ 𝑏𝑖𝑣𝑖𝑖∊ℎ𝑖𝑑𝑑𝑒𝑛 − ∑ 𝑣𝑖ℎ𝑗𝑤𝑖𝑗𝑖,𝑗                         (1) 
 
where 𝑣𝑖 and ℎ𝑗  are the ith visible variable and the jth hidden variable, i.e., the 
original input 𝑖 and the feature 𝑗 in the feature space; 𝑏𝑖 and 𝑏𝑗  are the biases to the 
nodes, and 𝑤𝑖𝑗  is the connection weight between them. The RBM assigns a 
probability to every possible pair of visible and hidden variables using the energy 
function  
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where 𝑍 is the sum of all the possible pairs of the visible and hidden variables 
expressed as 
 
                                                           𝑍 = ∑ 𝑒𝐸(𝑣,ℎ)
𝑣,ℎ
                                                             (3) 
 
The probability of the visible v  is given as 
 
                                                  𝑃(𝑣) =
1
𝑍
∑ 𝑒−𝐸(𝑣,ℎ)ℎ                                   (4) 
 
To minimize the energy of that input data, the weights and the biases will be 
adjusted by  
 
                                          ∆𝑤𝑖𝑗 = 𝜂(〈𝑣𝑖ℎ𝑖〉 − 〈𝑣𝑖
′ℎ𝑖
′〉)                                    (5) 
 
where 𝜂 is the learning rate, and 〈•〉 denotes the expectation under the distribution of 








Fig. 2. Typical structure of RBM. 
In practice, a single RBM may not be sufficient to extract features with a reduced 
dimensionality. Often several RBMs are used in a sequential way, forming stacked 
RBMs layer-by-layer. The outputs of a trained RBM in the stack is used as the inputs 
to the next adjacent RBM for training. The number of RBMs to be used varies and 
usually is determined using a trial-and-error approach. For a detailed guidance on the 
training the readers can refer to, for example, [22].  
3.2 k-means Cluster Analysis 
k-means clustering is one of the most popular algorithms in data mining for grouping 
samples into a certain number of groups (clusters) based on Euclidean distance 
measure. Assume 𝑉1, 𝑉2, ⋯ , 𝑉𝑛 are a set of vectors, and these vectors are to be 
assigned to k clusters 𝑆1, 𝑆2, ⋯ , 𝑆𝑘. Then the objective function of the k-means 















𝑖=1                                    (6) 
where 𝑚𝑖 represents the centroid of cluster 𝑆𝑖. 
4 Data Pre-processing 
The SEER breast cancer data explored in this study contains totally 291,760 
incidences registered in the US from 1974 to 2017. The data set has two separate 
collections with incidences from 1974 to 2014 and 2014 to 2017, respectively. Note 
that the number of variables in the two sets of collections is 134 and 130, respectively. 
Most of the variables in the data set are categorical type with a varying number of 
distinct values from 2 to more than 100. The original data sets need to be pre-
processed and transformed to a target data set for analysis. The most crucial task in 
the data pre-processing process is to identify if there are any data quality issues in the 
data and further to adopt appropriate strategies to address them accordingly.  
The SEER data under consideration has typical data quality problems, including 
inconsistent variables in the two collections of the data, some duplicate variables and 
therefore directly or indirectly correlated to each other, missing values, and in-
comparative value ranges for several numeric variables. As such, the main tasks 
involved in the data pre-processing are as follows: 
1. Select meaningful and common variables that are applicable to both sets of the 
data. Further, remove any duplicate variables that are identical from statistical 
perspective and/or from medical diagnostical perspective. As a result, a total 
of 130 variables have been chosen to use.  
2. Remove any incidences that contain missing value. The removal is reasonable 
and acceptable since the entire data set is big and there were only some 10,000 
incidences containing missing values. As such no replacement of missing 
value is needed. 
3. Transform the value range of each numeric variable into a unit interval [0,1] 
using the min-max normalization. 
4. Represent each distinct value of a categorical value as a unit vector using the 
one-hot encoding. This leads to a significant number of dummy variables to be 
created.  
The data pre-processing process was very time-consuming, and it has eventually 
led to a resultant target data set with 260000 incidences and 961 variables. The 
variable Survival that represents if a patient survived has been considered the target 
variable since this analysis is aiming at identifying crucial factors that potentially 
affect the survival of a breast cancer patient.  
It should be noted that no incidences have been removed although they may be 
considered outliers, and this is because each instance should be analysed.  
5 Experimental Settings 
Using the target data set created, RBMs have been implemented for dimensionality 
reduction and feature extraction, and further the k-means clustering analysis has been 
applied to the samples in the feature space formed by the RBMs. 
Three RBM models, RBM_1, RBM_2 and RBM_3, have been constructed in a 
sequential manner as follows: 
• RBM_1 has 961 input nodes and 625 (25 × 25 ) hidden nodes;  
• RBM_2 has 625 input nodes and 169 (13 × 13 ) hidden nodes; and  
• RBM_3 has 169 input nodes and 81 (9 × 9 ) hidden nodes.  
RBM_1 needs to be trained using the target data set; RBM_2 needs to be trained 
using the outputs of the trained RBM_1, and RBM_3 needs to be trained using the 
outputs of the trained RBM_2. In other words, the original data in a 961-dimensioanl 
space has been transformed into an 81-dimesional space for analysis.  
RBM_1, RBM_2, and RBM_3 have been trained with 10,000, 20,000, and 20,000 
iterations, respectively. The initial values of all the connection weights and the biases 
were randomly selected from a uniform distribution in the interval [-1, 1].  
Following the entire analysis process as shown in Fig. 1, the k-means clustering 
analysis has been applied to the outputs of RBM_3. The number of centroids was set 
to 6 with randomly selected initial centroids to start the clustering process.  
6 Pattern Interpretations and Findings 
In order to interpret each of the clusters created for diagnosis purpose, the results 
obtained about the cluster membership of all the samples have been mapped back to 
the original space (of 961 dimensions) since the variables in each of the lower 
dimensional spaces is not interpretable. 
Note that each instance of a patient’s records in each of the spaces, e.g., the 
original and all the RBM spaces, can be visualized by a “facial” like imagery and this 
enables each patient’s profile can be compared with each other in an initiative and 
easy way. Examples of such imagery description are provided in Figure 3, where each 
two rows from the top to the bottom contains 10 patients’ profile of the same cluster 
in the RBM_3 (81 dimensions) space and their counterparts in the original (961 
dimensions) spaces, respectively. Only samples from 4 out of the 6 clusters created 
were selected. The value for each pixel of the images is either 1 or 0 if a component 
associated is binary data type, or between 0 and 1 if the component associated is 
numeric data type, indicting a scale grading between black and white, especially in 




Fig. 3. Samples of a patient’s profile in a “facial” like imagery description. Each two rows from 
the top to the bottom contains 10 patients’ profile of the same cluster in the RBM_3 (81 
dimensions) space and their counterparts in the original (961 dimensions) spaces, respectively. 
The six clusters are labelled as Clusters 0, 1, …, and 5. To examine the clusters, 
and to compare them with each other, several variables have been used as shown in 
Table 1. In terms of factors affecting survival rate, there are several factors are crucial 
as highlighted in yellow in the Table.  
It appears that if a patient had a surgery performed and the stage of tumor are two 
essential casual attributors. The survival rate for those who either didn’t have surgery 
performed or were not recommended for a surgery had a very low survival rate (only 
25%). In addition, patients in this group usually had a stage IV or not known tumor. 
As such accurately and timely detect the stage of a tumor and recommend on having a 
surgery or not accordingly is crucial.  
Table 1. Table captions should be placed above the tables. 
Cluster 0 1 2 3 4 5 
Survival (%) 25.00 92.00 72.00 89.00 74.00 78.00 
Grade (%)       
Grade 1   7.00  23.00  10.00  14.00 3.00 32.00 
Grade 2 27.00  45.00  41.00 31.00 8.00 59.00 
Grade 3 31.00  24.00  43.00 27.00 80.00   3.00 
Grade 4   3.00    0.00    1.00   2.00   3.00   0.00 
Cell not 
Determined  32.00  8.00   5.00 26.00  6.00   6.00 
Number of 
Malignant 
Tumors       
1 58.00   1.00 68.00   47.00 64.00   57.00   
2 33.00   71.00   26.00   39.00   28.00   33.00   
3   7.00  23.00    5.00   11.00    7.00    8.00   
4   2.00     4.00   1.00    2.00    1.00    1.00   
5   0.00     1.00   0.00    1.00    0.00    1.00   
6   0.00     0.00   0.00    0.00    0.00    0.00   
7   0.00     0.00   0.00    0.00    0.00    0.00   
Treatment       
Surgery Performed 38.00   95.00   99.00   95.00   99.00   99.00   
Surgery not 
Recommended 34.00    2.00    1.00    3.00    1.00    1.00   
Contraindicated  2.00    0.00    0.00    0.00    0.00    0.00   
Died before  0.00    0.00    0.00    0.00    0.00    0.00   
Unknown Reason 
for No Surgery 15.00   1.00   0.00   2.00   0.00   0.00   
Refused  4.00   1.00   0.00   0.00   0.00   0.00   
Recommended  1.00    1.00    0.00    0.00    0.00    0.00   
Unknown if 
Surgery Performed  6.00    0.00    0.00    0.00    0.00    0.00   
Alive or Died due 
to Cancer 24.00    1.00   65.00   57.00   68.00   67.00   
Dead 41.00    0.00   15.00    1.00     7.00     3.00   
Not first Tumor 35.00   99.00   20.00   42.00   25.00   30.00   
In Situ     0.00     3.00       0.00   99.00      0.00       0.00   
Malignant 100.00   97.00   100.00     1.00   100.00   100.00   
Primaries       
One primary only 58.00     1.00   67.00   47.00   63.00   57.00   
First of Two or 
More Primaries   6.00     0.00   12.00   12.00   12.00   13.00   
Second of Two or 
More Primaries 30.00   79.00   18.00   34.00   22.00   26.00   
Third of Three or 
More Primaries 4.00   16.00   2.00   6.00     3.00     4.00   
Fourth of Four or 
More Primaries 1.00   3.00   0.00   1.00     0.00     0.00   
Fifth of Five or 
More Primaries 0.00   0.00   0.00   0.00     0.00     0.00   
Sixth of Six or 
More Primaries 0.00   0.00   0.00   0.00     0.00     0.00   
Seventh of Seven 
or More Primaries 0.00   0.00   0.00   0.00     0.00     0.00   
Eighth of Eight or 
More Primaries 0.00   0.00   0.00   0.00      0.00     0.00   
Ninth of Nine or 
More Primaries 0.00   0.00   0.00   0.00     0.00     0.00   
Unknown 0.00   0.00   0.00   0.00     0.00     0.00   
Stage       
Stage 0 0.00   3.00   0.00   99.00   1.00   0.00   
Stage I 2.00   62.00   1.00   0.00   62.00   84.00   
Stage IIA 2.00   21.00   36.00   0.00   30.00   12.00   
Stage IIB 2.00   6.00   28.00   0.00   3.00   1.00   
Stage III NOS 1.00   0.00   0.00   0.00   0.00   0.00   
Stage IIIA 2.00   2.00   22.00   0.00   0.00   0.00   
Stage IIIB 8.00   1.00   3.00   0.00   1.00   0.00   
Stage IIIC 4.00   1.00   9.00   0.00   0.00   0.00   
Stage IV 41.00   1.00   0.00   0.00   0.00   0.00   
Not Applicable 2.00   0.00   0.00   0.00   0.00   0.00   
Stage Unknown 36.00   3.00   2.00   0.00   2.00   2.00   
 
A consistent pattern can be identified if, for example, examining the two clusters, 
Cluster 0 and Cluster 1, using a radar graph as shown in Figure 3.   
It is evident from Figure 3 that high survival rate was closely correlated with if a 
tumor was localized and if a surgery was performed. On the other hand, low survival 
was in general related to a tumor was regional and distant, and a surgery was not 
performed.  
 
Fig. 3. Low survival rate (in blue) vs. high survival rate (in red) with several factors. 
7 Concluding Remark and Future Work 
In this paper, a deep learning-based approach is applied to high dimensional, high-
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might affect the survival of a breast cancer patient. The analysis has demonstrated that 
essential features in a high-dimensional sample space can be effectively extracted and 
brought forward into a much lower dimensionality space formed by RBMs. This has 
provided a novel approach to understand high-dimensional data.   
The analysis has also identified several crucial casual factors that significantly 
affect a patient’s survival rate among all the variables.  
Further research will focus on exploring what features RBM extracts, how to 
interpret the feature space established by an RBM and design an ideal imaginary 
description for visualizing a healthy person for comparison purpose.  
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